| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Medicine, University of North Carolina, Chapel Hill, NC 27599; and
Division of Nephrology, Department of Medicine, Duke University and Durham Veterans Affairs Medical Centers, Durham, NC 27705
Leukotrienes (LT) are potent lipid mediators synthesized by the 5-lipoxygenase pathway of arachidonic acid (AA) metabolism. LT have been implicated in a broad spectrum of inflammatory processes. To investigate the influence of genetic factors on the contribution of LT to acute inflammation, we generated congenic 5-lipoxygenase-deficient 129, C57BL/6 (B6), and DBA/1Lac (DBA) mouse lines. Topical application of AA evoked a vigorous inflammatory response in 129 and DBA mice, whereas only a modest response was seen in B6 animals. The response to AA in 129 and DBA strains is LT dependent. In contrast, LT make little contribution to this response in B6 mice. AA-induced inflammation in B6 mice is prostanoid dependent, since this response was substantially reduced by treating B6 mice with a cyclooxygenase inhibitor. These data suggest that prostanoids are essential for AA-induced cutaneous inflammation in B6 mice, whereas LT are the major mediators of this response in 129 and DBA strains. In contrast, the response to AA in the peritoneal cavity is robust in the 129 and B6 strains, but was significantly blunted in DBA mice, showing that strain differences in the response to AA are tissue specific. Variations in these and other experimental models of inflammation appear to correlate directly with the ability of a particular mouse strain and a specific tissue to respond to LT, specifically LTC4. Taken together, these findings indicate that the relative contribution of prostanoids and LT to inflammatory responses is variable not only between strains but also between different tissues within these inbred mouse lines.
This article has been cited by other articles:
|
|
 |
|
  K. Wada, M. Arita, A. Nakajima, K. Katayama, C. Kudo, Y. Kamisaki, and C. N. Serhan Leukotriene B4 and lipoxin A4 are regulatory signals for neural stem cell proliferation and differentiation FASEB J, September 1, 2006; 20(11): 1785 - 1792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nguyen, A. J. Pace, and B. H. Koller Age-Induced Reprogramming of Mast Cell Degranulation J. Immunol., November 1, 2005; 175(9): 5701 - 5707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Caironi, F. Ichinose, R. Liu, R. C. Jones, K. D. Bloch, and W. M. Zapol 5-Lipoxygenase Deficiency Prevents Respiratory Failure during Ventilator-induced Lung Injury Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 334 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hakonarson, S. Thorvaldsson, A. Helgadottir, D. Gudbjartsson, F. Zink, M. Andresdottir, A. Manolescu, D. O. Arnar, K. Andersen, A. Sigurdsson, et al. Effects of a 5-Lipoxygenase-Activating Protein Inhibitor on Biomarkers Associated With Risk of Myocardial Infarction: A Randomized Trial JAMA, May 11, 2005; 293(18): 2245 - 2256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Trebino, J. D. Eskra, T. S. Wachtmann, J. R. Perez, T. J. Carty, and L. P. Audoly Redirection of Eicosanoid Metabolism in mPGES-1-deficient Macrophages J. Biol. Chem., April 29, 2005; 280(17): 16579 - 16585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ogasawara, S. Ishii, T. Yokomizo, T. Kakinuma, M. Komine, K. Tamaki, T. Shimizu, and T. Izumi Characterization of Mouse Cysteinyl Leukotriene Receptors mCysLT1 and mCysLT2. DIFFERENTIAL PHARMACOLOGICAL PROPERTIES AND TISSUE DISTRIBUTION J. Biol. Chem., May 17, 2002; 277(21): 18763 - 18768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Aiello, P.-A. Bourassa, S. Lindsey, W. Weng, A. Freeman, and H. J. Showell Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in Mice Arterioscler Thromb Vasc Biol, March 1, 2002; 22(3): 443 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Goulet, R. C. Griffiths, P. Ruiz, R. B. Mannon, P. Flannery, J. L. Platt, B. H. Koller, and T. M. Coffman Deficiency of 5-Lipoxygenase Accelerates Renal Allograft Rejection in Mice J. Immunol., December 1, 2001; 167(11): 6631 - 6636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-Z. Shi, B. Han, G. M. Habib, M. M. Matzuk, and M. W. Lieberman Disruption of {gamma}-Glutamyl Leukotrienase Results in Disruption of Leukotriene D4 Synthesis In Vivo and Attenuation of the Acute Inflammatory Response Mol. Cell. Biol., August 15, 2001; 21(16): 5389 - 5395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Chen and C. S. Yang Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention Carcinogenesis, August 1, 2001; 22(8): 1119 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ichinose, W. M. Zapol, A. Sapirstein, R. Ullrich, A. M. Tager, K. Coggins, R. Jones, and K. D. Bloch Attenuation of Hypoxic Pulmonary Vasoconstriction by Endotoxemia Requires 5-Lipoxygenase in Mice Circ. Res., April 27, 2001; 88(8): 832 - 838. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
